Max P. Seiler

421 total citations
13 papers, 338 citations indexed

About

Max P. Seiler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Max P. Seiler has authored 13 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Max P. Seiler's work include Receptor Mechanisms and Signaling (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). Max P. Seiler is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). Max P. Seiler collaborates with scholars based in Switzerland, France and United States. Max P. Seiler's co-authors include R. Markstein, Philippe Schoeffter, A. Stoll, Daniël Hoyer, Werner Müller, John R. Fozard, Erika Loetscher, Dominik Feuerbach, Jean‐François Cloix and Irving W. Wainer and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Max P. Seiler

13 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max P. Seiler Switzerland	11	210	210	65	44	28	13	338
E Grana Italy	11	244 1.2×	144 0.7×	48 0.7×	73 1.7×	24 0.9×	65	429
Jon K. Reel United States	11	242 1.2×	212 1.0×	75 1.2×	66 1.5×	18 0.6×	14	393
Robert N. Cory France	9	331 1.6×	315 1.5×	44 0.7×	92 2.1×	20 0.7×	10	515
A.T. Kilpatrick United Kingdom	13	297 1.4×	276 1.3×	71 1.1×	58 1.3×	21 0.8×	23	495
Yuzo Matsuoka Japan	12	134 0.6×	136 0.6×	68 1.0×	28 0.6×	28 1.0×	34	370
Dana N. Loury United States	14	403 1.9×	287 1.4×	53 0.8×	86 2.0×	39 1.4×	24	610
M Dóda Hungary	10	158 0.8×	154 0.7×	67 1.0×	71 1.6×	7 0.3×	39	377
Tsutomu Uruno Japan	11	170 0.8×	149 0.7×	21 0.3×	61 1.4×	18 0.6×	52	352
Anne Renouard France	9	212 1.0×	191 0.9×	17 0.3×	86 2.0×	17 0.6×	10	373
H. Greney France	11	279 1.3×	248 1.2×	37 0.6×	55 1.3×	14 0.5×	21	401

Countries citing papers authored by Max P. Seiler

Since Specialization

Citations

This map shows the geographic impact of Max P. Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max P. Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max P. Seiler more than expected).

Fields of papers citing papers by Max P. Seiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max P. Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max P. Seiler. The network helps show where Max P. Seiler may publish in the future.

Co-authorship network of co-authors of Max P. Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of Max P. Seiler. A scholar is included among the top collaborators of Max P. Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max P. Seiler. Max P. Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Loetscher, Erika, et al.. (2004). Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. European Journal of Pharmacology. 495(2-3). 97–102. 48 indexed citations

Seiler, Max P., Philipp Floersheim, R. Markstein, & Armin Widmer. (1993). Structure-activity relationships in the trans-hexahydroindolo[4,3-ab]phenanthridine ("benzergoline") series. 2. Resolution, absolute configuration, and dopaminergic activity of the selective D1 agonist CY 208-243 and its implication for an "extended rotamer-based dopamine receptor model". Journal of Medicinal Chemistry. 36(8). 977–984. 6 indexed citations

Schoeffter, Philippe, et al.. (1993). SDZ 216–525, a selective and potent 5-HT1A receptor antagonist. European Journal of Pharmacology Molecular Pharmacology. 244(3). 251–257. 45 indexed citations

Markstein, R., Max P. Seiler, A.L. Jaton, & U. Briner. (1992). Structure activity relationship and therapeutic uses of dopaminergic ergots. Neurochemistry International. 20. 211–214. 13 indexed citations

Hoyer, Daniël, et al.. (1991). 5‐HT₁‐like receptors mediate 5‐hydroxytryptamine‐induced contraction of guinea‐pig isolated iliac artery. British Journal of Pharmacology. 102(2). 386–390. 43 indexed citations

Seiler, Max P., et al.. (1991). trans-Hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group. Journal of Medicinal Chemistry. 34(1). 303–307. 20 indexed citations

Seiler, Max P., et al.. (1991). ChemInform Abstract: trans‐Hexahydroindolo(4,3‐ab)phenanthridines (“Benzergolines”), the First Structural Class of Potent and Selective Dopamine D1 Receptor Agonists Lacking a Catechol Group.. ChemInform. 22(24). 1 indexed citations

Seiler, Max P., et al.. (1989). Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.. Molecular Pharmacology. 35(5). 643–651. 10 indexed citations

Büscher, Heinz H., D. Römer, Richard A. Maurer, et al.. (1988). CY 208–243: A unique combination of atypical opioid antinociception and D1 dopaminomimetic properties. Life Sciences. 42(2). 137–152. 13 indexed citations

10.

Seiler, Max P., et al.. (1986). Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents. Journal of Medicinal Chemistry. 29(6). 912–917. 28 indexed citations

11.

Cloix, Jean‐François, Maryse Crabos, Irving W. Wainer, et al.. (1985). High yield-purification of a urinary Na+-pump inhibitor. Biochemical and Biophysical Research Communications. 131(3). 1234–1240. 44 indexed citations

12.

Seiler, Max P. & R. Markstein. (1984). Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.. Molecular Pharmacology. 26(3). 452–457. 31 indexed citations

13.

Seiler, Max P. & R. Markstein. (1982). Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.. Molecular Pharmacology. 22(2). 281–289. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact